Brief: Eiger Biopharmaceuticals William G. Kachioff Appointed As Chief Financial Officer
13/04/2023 14:29
April 13 (Reuters) - Eiger BioPharmaceuticals Inc
EIGR.O :
* WILLIAM G. KACHIOFF APPOINTED AS CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nPn1TDjBXa
Further company coverage: EIGR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview